Over 10 years we help companies reach their financial and branding goals. Engitech is a values-driven technology agency dedicated.

Gallery

Contacts

411 University St, Seattle, USA

engitech@oceanthemes.net

+1 -800-456-478-23

Development Technology

Machine learning in drug discovery at Bayer Pharmaceuticals: from models to molecules



👀 *All of the Fully Connected London 2024 videos are available at http://wandb.me/fclondon24yt*

*About Marc Osterland’s Session on Machine Learning in Drug Discovery: From Models to Molecules*

Join Marc Osterland, ML Engineer at Bayer, as he explores the transformative impact of machine learning on pharmaceutical research. This session focuses on how ML is revolutionizing the drug discovery process, from identifying potential drug targets to optimizing candidate molecules.

*Key points covered in the session include:*

– An overview of the drug discovery process and where machine learning can make a significant impact.
– Techniques for lead identification, including morphological profiling and in silico high-throughput screening.
– The integration of machine learning models to predict absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties.
How self-supervised learning and data integration enhance the efficiency and accuracy of drug discovery.
– The future of drug discovery with AI, including the potential for digital twins and the reduction of animal testing.

Discover how Bayer is leveraging cutting-edge machine learning techniques to streamline drug development and bring new therapies to market faster and more efficiently.

source

Author

MQ

Leave a comment

Your email address will not be published. Required fields are marked *